{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:55:25Z","timestamp":1783472125662,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.cancergen.2016.03.003","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T08:30:25Z","timestamp":1459845025000},"page":"199-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic"],"prefix":"10.1016","volume":"209","author":[{"given":"M.","family":"Borecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Zemankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Soucek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Soukupova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Kleiblova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sevcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2050-9667","authenticated-orcid":false,"given":"Z.","family":"Kleibl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Janatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2016.03.003_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1158\/1055-9965.EPI-15-0455","article-title":"Prevalence of pathogenic mutations in cancer predisposition genes among pancreatic cancer patients","volume":"25","author":"Hu","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1159\/000320068","article-title":"Epidemiology of pancreatic cancer: an update","volume":"28","author":"Maisonneuve","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0020","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1053\/j.gastro.2015.07.057","article-title":"Genetics and genetic testing in pancreatic cancer","volume":"149","author":"Whitcomb","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pathmechdis.3.121806.154305","article-title":"Pancreatic cancer","volume":"3","author":"Maitra","year":"2008","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0030","doi-asserted-by":"crossref","first-page":"11182","DOI":"10.3748\/wjg.v20.i32.11182","article-title":"Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection","volume":"20","author":"Becker","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0035","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1055-9965.EPI-06-0783","article-title":"The prevalence of BRCA2 mutations in familial pancreatic cancer","volume":"16","author":"Couch","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0040","doi-asserted-by":"crossref","first-page":"10778","DOI":"10.3748\/wjg.v20.i31.10778","article-title":"Genetic predisposition to pancreatic cancer","volume":"20","author":"Ghiorzo","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0045","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature05609","article-title":"A recurrent mutation in PALB2 in Finnish cancer families","volume":"446","author":"Erkko","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-5751-8-12","article-title":"PALB2 variants in hereditary and unselected Finnish prostate cancer cases","volume":"8","author":"Pakkanen","year":"2009","journal-title":"J Negat Results Biomed"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0055","doi-asserted-by":"crossref","first-page":"e100683","DOI":"10.1371\/journal.pone.0100683","article-title":"Assessment of PALB2 as a candidate melanoma susceptibility gene","volume":"9","author":"Aoude","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0060","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","article-title":"Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2","volume":"22","author":"Xia","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0065","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ng1947","article-title":"Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer","volume":"39","author":"Reid","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0070","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1158\/1055-9965.EPI-13-0745-T","article-title":"The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer","volume":"22","author":"Janatova","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0075","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.canep.2010.06.008","article-title":"CHEK2 gene alterations in the forkhead-associated domain, 1100delC and del5395 do not modify the risk of sporadic pancreatic cancer","volume":"34","author":"Mohelnikova-Duchonova","year":"2010","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0080","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1158\/0008-5472.CAN-10-3958","article-title":"Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer","volume":"71","author":"Casadei","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0085","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10549-010-1001-1","article-title":"PALB2 analysis in BRCA2-like families","volume":"127","author":"Adank","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0090","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10549-010-1290-4","article-title":"PALB2 mutations in German and Russian patients with bilateral breast cancer","volume":"126","author":"Bogdanova","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2350-11-20","article-title":"A novel germline PALB2 deletion in Polish breast and ovarian cancer patients","volume":"11","author":"Dansonka-Mieszkowska","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0100","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.1073\/pnas.1007983107","article-title":"Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing","volume":"107","author":"Walsh","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10689-009-9241-0","article-title":"PALB2 sequence variants in young South African breast cancer patients","volume":"8","author":"Sluiter","year":"2009","journal-title":"Fam Cancer"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10689-009-9295-z","article-title":"A PALB2 germline mutation associated with hereditary breast cancer in Italy","volume":"9","author":"Papi","year":"2010","journal-title":"Fam Cancer"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0115","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1171202","article-title":"Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene","volume":"324","author":"Jones","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0125","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/gim.2014.153","article-title":"BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study","volume":"17","author":"Zhen","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0130","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2014.11.042","article-title":"Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer","volume":"148","author":"Grant","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0135","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/j.gastro.2009.06.055","article-title":"Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer","volume":"137","author":"Tischkowitz","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10689-014-9755-y","article-title":"Familial and sporadic pancreatic cancer share the same molecular pathogenesis","volume":"14","author":"Norris","year":"2015","journal-title":"Fam Cancer"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1158\/2159-8290.CD-15-0402","article-title":"Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer","volume":"6","author":"Roberts","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0155","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1399-0004.2010.01425.x","article-title":"PALB2 mutations in European familial pancreatic cancer families","volume":"78","author":"Slater","year":"2010","journal-title":"Clin Genet"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0160","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/ejhg.2011.226","article-title":"Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated","volume":"20","author":"Harinck","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0165","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/jmedgenet-2011-100281","article-title":"CDKN2A is the main susceptibility gene in Italian pancreatic cancer families","volume":"49","author":"Ghiorzo","year":"2012","journal-title":"J Med Genet"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1479-7364-7-11","article-title":"Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer","volume":"7","author":"Grant","year":"2013","journal-title":"Hum Genomics"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0175","doi-asserted-by":"crossref","first-page":"e67538","DOI":"10.1371\/journal.pone.0067538","article-title":"Analysis of PALB2 gene in BRCA1\/BRCA2 negative Spanish hereditary breast\/ovarian cancer families with pancreatic cancer cases","volume":"8","author":"Blanco","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0180","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10689-011-9426-1","article-title":"PALB2 mutations in familial breast and pancreatic cancer","volume":"10","author":"Hofstatter","year":"2011","journal-title":"Fam Cancer"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0185","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/jmg.2010.087379","article-title":"Germline PALB2 mutation analysis in breast-pancreas cancer families","volume":"48","author":"Stadler","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0190","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10549-010-1305-1","article-title":"PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer","volume":"126","author":"Peterlongo","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10689-011-9483-5","article-title":"Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy","volume":"11","author":"Ghiorzo","year":"2012","journal-title":"Fam Cancer"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0200","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1158\/1541-7786.MCR-09-0123","article-title":"PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2","volume":"7","author":"Zhang","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/TACG.S34116","article-title":"PALB2 and breast cancer: ready for clinical translation!","volume":"6","author":"Southey","year":"2013","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0210","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","article-title":"Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond","volume":"1","author":"Hansford","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0220","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10689-008-9220-x","article-title":"Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations","volume":"8","author":"Kim","year":"2009","journal-title":"Fam Cancer"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0225","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1002\/cncr.29664","article-title":"Identification of germline genetic mutations in patients with pancreatic cancer","volume":"121","author":"Salo-Mullen","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0230","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/gutjnl-2012-303108","article-title":"International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer","volume":"62","author":"Canto","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0235","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/bjc.2014.418","article-title":"Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers","volume":"111","author":"Golan","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-10-0893","article-title":"Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer","volume":"10","author":"Villarroel","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.cancergen.2016.03.003_bib0245","first-page":"1417","article-title":"Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer","volume":"31","author":"Fogelman","year":"2011","journal-title":"Anticancer Res"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776216300382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776216300382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:40:28Z","timestamp":1761896428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776216300382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S2210776216300382"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.03.003","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}